All of Us Pennsylvania
我们所有人宾夕法尼亚州
基本信息
- 批准号:10327863
- 负责人:
- 金额:$ 1200万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-08 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAgingAgricultureAmishBiomedical ResearchCancer CenterCaringCatchment AreaChemicalsChildClinicClinicalClinical DataClinical SciencesClinical Trials NetworkCollaborationsCommunicationCommunitiesCommunity ServicesConsentDataDecision MakingDiagnosisDiseaseEaglesEducationElderlyElectronic Health RecordElectronic MailEmergency SituationEnrollmentEnsureEnvironmental ExposureEvaluationExposure toFederally Qualified Health CenterFundingGeneticGroup ProcessesHealthHealth Planning OrganizationsHealth care facilityHealth systemHospitalsHumanIndustryInfrastructureInpatientsInstitutesLaboratoriesLatinoLife StyleLinkLocationLong-Term CareMedical centerMennoniteMethodsMiningMultimediaNeighborhood Health CenterOperative Surgical ProceduresOutpatientsParticipantPatientsPediatric HospitalsPediatricsPennsylvaniaPersonsPharmaceutical PreparationsPharmacy facilityPhasePopulationPopulation GroupPopulation HeterogeneityPopulation ResearchPrecision Medicine InitiativeProceduresProcessProviderRegistriesRehabilitation therapyResearchResearch InstituteResourcesRuralSamplingServicesSiteStatistical Data InterpretationSteelStructureSystemTest ResultThinkingTranslational ResearchUnited States National Institutes of HealthUniversitiesVisitWomanaging populationbasecohortcommunity organizationsdata warehousedemographicsdesigndietarydisabilityexperiencefollow-uphealth disparityhuman old age (65+)implementation processinfancymedical specialtiesmembernoveloperationpreferenceprogramsrecruitrural countiessocial mediatool
项目摘要
The PA Cares for Us Research Program (PA Cares) at the University of Pittsburgh (Pitt)/UPMC (University of
Pittsburgh Medical Center) is a regional medical center (RMC) enrollment site for the NIH All of Us (AoU)
Precision Medicine Initiative. As of November 13, 2017, we piloted an array of engagement methods, launched
3 enrollment strategies, and during the AoU beta phase fully enrolled 2005 participants who closely match our
originally projected demographic distribution. We will now further leverage the continually expanding clinical
footprint of UPMC and the infrastructure created by our NIH-funded Clinical and Translational Science
Institute (CTSI), which we direct, to fully enroll at least 111,002 AoU participants to achieve a retained cohort
of ≥93,000 participants with:
Sufficient diversity to enable AoU’s million person cohort to achieve adequate power for evaluation of
common disorders from infancy to old age. We will leverage UPMC’s expanding clinical operations in
western and central Pennsylvania, our CTSI Community PARTners Core’s focus on eliminating health
disparities, and our comprehensive PA Cares engagement plan that we designed with our stakeholders.
Examples of resources that we will leverage to enroll adults, and eventually children, include:
o 37 UPMC hospitals and >600 points of service across western and central Pennsylvania
o 23 UPMC Senior Communities serving >2900 older adult residents
o Hillman Cancer Center plus a network of >60 community cancer centers
o >90 rehabilitation and long-term care facilities plus a planned disability hospital
o Pitt/UPMC Aging Institute and partner organizations
o Giant Eagle Pharmacy (219 locations throughout Pennsylvania)
o >150 community organizations actively partnering with the CTSI Community PARTners Core, including
close collaborations with the Urban League of Greater Pittsburgh, FOCUS Pittsburgh, and several Latino
organizations
o PA Cares Stakeholder Advisory Board (SAB) representing diverse groups, including those
underrepresented in biomedical research (UBR), and participant partners
o 14 UPMC hospitals located in rural counties (e.g., UPMC Altoona, UPMC Bedford, recently acquired
Susquehanna Health System)
o UPMC Children’s Hospital of Pittsburgh (FY17: 12,333 inpatient stays; 9,693 observation stays; 146,748
emergency/express care visits; 23,389 surgeries; >1M outpatient visits)
o UPMC Children’s Community Pediatrics network (>40 practices, >200 providers, >200,000 patients)
o UPMC Magee Women’s Hospital (>11,000 deliveries annually)
Intentional and directed over-sampling of populations historically underrepresented in biomedical
research to enable AoU to have sufficient power for statistical analyses in order to help understand the
specific health conditions and disparities affecting these population groups. We will use novel tools,
design thinking approaches, targeted messaging, and nimble PA Cares enrollment methods, such as:
o Pitt+Me Research Participant Registry (>134,000 consented participants who receive study invitations
based on electronic health record (EHR) data, demographics, and preferences; >9,500 new Registry
enrollees in past 2 months alone)
o NIH/NCATS Accrual to Clinical Trials (ACT) network of linked EHRs to target specific demographic
groups (across 37 UPMC hospitals & >600 offices and deployment by at least 18 AoU RMC sites by 2019)
o TrialSpark (social media tool for targeting specific demographics)
o UPMC Altoona and Bedford Hospitals with expansion to UPMC Susquehanna and Pinnacle Health
Systems (rural and urban central PA) and UPMC Northwest, Horizon, and Hamot Hospitals (rural and
urban northwestern PA)
o Nimble pop-up engagement and enrollment teams to reach Community Health Centers, Federally
Qualified Health Centers, Free Clinics, and other specialty care venues that care for UBR populations
A broad range of genetic backgrounds, dietary, lifestyle, and environmental exposure assessments. We
will capitalize on the demographics of western and central Pennsylvania, including:
o UPMC’s diverse catchment area (Figure 1)
o Stable aging population with longitudinally documented exposure to mining, steel, chemical,
manufacturing, agriculture, and other industries
o Large Mennonite and Amish communities serviced by our providers
A broad array of clinical and laboratory information via EHR, not limited to any single disease through:
o UPMC EHR, which contains comprehensive in- and outpatient data collected since 2004
o CTSI Research Data Warehouse, which comprises structured clinical data for each patient that has been
aggregated from UPMC’s EHR systems and includes demographics, diagnoses, procedures, medications,
and laboratory test results
An engagement, recruitment and implementation process that ensures a high follow-up rate and
comparable follow up rates across diverse population groups. Our retention plans are based on the
concept of providing value to participants and leverages our previous experiences. We will:
o Deploy our Pitt+Me recruitment framework for mail/email communications with PA Cares participants
o Be guided by our SAB (we embrace an inclusive decision-making process to develop and adjust methods
to meet participants’ needs)
o Leverage the MyUPMC health portal, which can be used to engage and recruit from among >540,000
patient users and provide general education about types of results returned by AoU
o Leverage UPMC Health Plan communications with its 3.2 million members
o Employ multi-media engagement and retention tools created by Wondros based on a human-centered
design approach
o Employ efficient project management with guidance from The Chartis Group (process management)
匹兹堡大学(皮特)/UPMC(匹兹堡大学)的PA Cares for Us研究项目(PA Cares)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Oscar C. Marroquin其他文献
PLATELET REACTIVITY TESTING FOLLOWING CORONARY PERCUTANEOUS INTERVENTION IS INDEPENDENT OF THE INITIAL CLINICAL PRESENTATION
- DOI:
10.1016/s0735-1097(10)61948-1 - 发表时间:
2010-03-09 - 期刊:
- 影响因子:
- 作者:
Firas Zahr;Rosalyn Rapsinski;Roy Semaan;Oscar C. Marroquin;Suresh Mulukulta;Conrad Smith;Ashley Lee;Sun Scolieri;Joon S. Lee;John T. Schindler;William D. Anderson;Catalin Toma - 通讯作者:
Catalin Toma
LONG-TERM OUTCOMES OF DRUG-ELUTING STENTS FOR OFF-LABEL INDICATIONS: A REPORT FROM THE NHLBI DYNAMIC REGISTRY
- DOI:
10.1016/s0735-1097(10)61716-0 - 发表时间:
2010-03-09 - 期刊:
- 影响因子:
- 作者:
Oscar C. Marroquin;Faith Selzer;Suresh R. Mulukutla;Joon S. Lee;Conrad Smith;William D. Anderson;Catalin Toma;David O. Williams;Sheryl F. Kelsey;Kevin E. Kip - 通讯作者:
Kevin E. Kip
COMPARATIVE EFFECTIVENESS OF RADIAL AND FEMORAL APPROACHES TO PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A REPORT FROM THE NHLBI DYNAMIC REGISTRY
- DOI:
10.1016/s0735-1097(10)62025-6 - 发表时间:
2010-03-09 - 期刊:
- 影响因子:
- 作者:
Sunil V. Rao;Faith Selzer;Eric D. Peterson;Suresh R. Mulukutla;Joon S. Lee;Howard A. Cohen;David O. Williams;Alice K. Jacobs;Sheryl F. Kelsey;Oscar C. Marroquin - 通讯作者:
Oscar C. Marroquin
Percutaneous Cardiac Assist with the Tandem Heart: The University of Pittsburgh Experience
- DOI:
10.1016/j.cardfail.2007.06.575 - 发表时间:
2007-08-01 - 期刊:
- 影响因子:
- 作者:
Aref M. Rahman;Marc A. Simon;Don A. Severyn;Suresh R. Mulukutla;Oscar C. Marroquin;John P. Pacella - 通讯作者:
John P. Pacella
Outcomes in Multivessel Coronary Disease Stratified by The Society of Thoracic Surgeons Risk
- DOI:
10.1016/j.athoracsur.2021.08.084 - 发表时间:
2022-08-01 - 期刊:
- 影响因子:
- 作者:
Saloni Kapoor;Jianhui Zhu;Arman Kilic;Catalin Toma;Ibrahim Sultan;Floyd Thoma;Conrad Smith;Oscar C. Marroquin;Forozan Navid;Joon S. Lee;Suresh R. Mulukutla - 通讯作者:
Suresh R. Mulukutla
Oscar C. Marroquin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Oscar C. Marroquin', 18)}}的其他基金
Precision Approach to healthCARE enrollment Site (PA CARES)
healthCARE 注册网站的精准方法 (PA CARES)
- 批准号:
9228293 - 财政年份:2016
- 资助金额:
$ 1200万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 1200万 - 项目类别:
Parkinson's disease and aging affect neural activation during continuous gait alterations to the split-belt treadmill: An [18F] FDG PET Study.
帕金森病和衰老会影响分体带跑步机连续步态改变期间的神经激活:[18F] FDG PET 研究。
- 批准号:
400097 - 财政年份:2019
- 资助金额:
$ 1200万 - 项目类别:
The elucidation of the mechanism by which intestinal epithelial cells affect impaired glucose tolerance during aging
阐明衰老过程中肠上皮细胞影响糖耐量受损的机制
- 批准号:
19K09017 - 财政年份:2019
- 资助金额:
$ 1200万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Does aging of osteocytes adversely affect bone metabolism?
骨细胞老化会对骨代谢产生不利影响吗?
- 批准号:
18K09531 - 财政年份:2018
- 资助金额:
$ 1200万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Links between affect, executive function, and prefrontal structure in aging: A longitudinal analysis
衰老过程中情感、执行功能和前额叶结构之间的联系:纵向分析
- 批准号:
9766994 - 财政年份:2018
- 资助金额:
$ 1200万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 1200万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 1200万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 1200万 - 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
- 批准号:
9925164 - 财政年份:2016
- 资助金额:
$ 1200万 - 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
- 批准号:
9345997 - 财政年份:2016
- 资助金额:
$ 1200万 - 项目类别:














{{item.name}}会员




